Local view for "http://purl.org/linkedpolitics/eu/plenary/2006-06-13-Speech-2-062"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20060613.6.2-062"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, Commissioner, ladies and gentlemen, I shall begin by thanking the rapporteur for his work and for the agreement that we have reached with a view to creating in this programme a specific line in favour of research into paediatric medicines.
A lot of things have been said in the context of putting this programme in place. That is why I shall emphasise only three points. Firstly, and on the subject of ease of access, I recently met a number of SME managers who told me that research grants would have to be requested for the purpose of understanding precisely how Europe tackles the subjects it has to deal with. Behind the humour, there is a great truth: yes to rigour in responding to requests, but no to the host of indecipherable formulas.
With regard, secondly, to the monitoring aspect, it is indeed necessary to strengthen this with a view to ensuring that the aid granted is effective and the funds properly used. We must act in accordance with these considerations.
Finally, the third point concerns the priority that it is absolutely vital to give to sustainable development, health research and innovation. Where health research and, more specifically, embryonic stem cell research is concerned, I would emphasise that we have to move with the times. Yes, I am in favour of this research. Yes, I want us to be able to help researchers work in good conditions and, above all, with no date restrictions when it comes to selecting the cells concerned. Indeed, date restrictions would amount to hindering cutting-edge research.
When voting, do not forget, ladies and gentlemen, that such research offers the possibility of identifying specific stem cell lines in order to find effective treatments. To reject these new lines of research would be to deprive those suffering from currently incurable diseases of the opportunity of a cure. By what right and under what law can we say to someone who is seriously ill: ‘No, Europe does not want anything to do with this research. If you had wanted to be treated, you should have been born in America.’ That, in point of fact, is where our problem lies. If we do not make up our minds and take action now, it will be the Americans and the Japanese who will do so in our place."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples